Designed for Pharmacists - Assessment Only

Thank you for engaging with the SAGED webinar session, "A Closer Look at Medical Cannabis and Chronic Pain". This completion module forms part of the overall training and is required to complete your CPD activity. Upon successful completion, you will receive a certificate confirming your completion of the webinar. You will also have the opportunity to provide feedback on your learning experience. If you have any questions or need support, please contact us at hello@saged.com.au. Estimated Duration: 5 minutes (excluding live session attendance) Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of the webinar session, you’ll be able to: Consider the validity and suitability of MC as a treatment option for CNCP Summarise the current evidence on the use of MC in the management of CNCP Evaluate the clinical evidence for MC in the treatment of neuropathic pain Identify key clinical features of neuropathic pain and determine when MC may be an appropriate therapeutic option Apply practical knowledge to clinical case scenarios, including considerations for product selection and dosing strategies

Thank you for attending the live SAGED training session, "Introduction to Medical Cannabis–With Real Patient Studies". This assessment module forms part of the overall training and is required to complete your CPD activity. Upon successful completion, you will receive a certificate confirming your attendance at the live session. You will also have the opportunity to provide feedback on your learning experience. If you have any questions or need support, please contact us at hello@saged.com.au. Estimated Duration: 5 minutes (excluding live session attendance) Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of the live training session, you’ll be able to: Describe the components and functions of the endocannabinoid system (ECS) and its role in human physiology. Differentiate between major cannabinoids, including their mechanisms of action, therapeutic applications, and adverse effect profiles. Explain the concept of the entourage effect and its implications for clinical practice. Evaluate the current clinical evidence for medical cannabis in the management of chronic non-cancer pain, anxiety, and sleep disturbance. Identify and assess safety considerations, including contraindications, common side effects, drug–drug interactions, and jurisdictional driving laws. Compare prescribing pathways available in Australia (Special Access Scheme and Authorised Prescriber models) and their regulatory requirements. Apply safe and evidence-informed prescribing principles, including dose titration strategies, to clinical scenarios. Integrate patient case studies and lived experiences to inform patient-centred decision-making in medical cannabis prescribing.

IMPORTANT: This assessment module is associated with the live training session, "Introduction to Medical Cannabis (for Pharmacists)". You will be asked to confirm your attendance at a live session to be able to claim CPD hours on completion of the module. Thank you for attending the live SAGED training session, "Introduction to Medical Cannabis (for Pharmacists)". This assessment module forms part of the overall training and is required to complete your CPD activity. Upon successful completion, you will receive a certificate confirming both your attendance at the live session and completion of the required assessment component. If you have any questions or need support, please contact us at hello@saged.com.au. Accreditation number: A2505IMC1. This activity has been accredited for 1.0 hour of Group 1 CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 1.0 hour of Group 2 CPD (or 2.0 CPD credits) upon successful completion of relevant assessment activities. Pharmacist Competencies: 1.3, 1.5, 2.1,2.2, 2.3, 3.1, 3.2, 3.5. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of the live training session and module, you’ll be able to: Describe the key components of the cannabis plant—including THC, CBD, and terpenes—and their relevance to clinical effects and patient experience. Explain the basic function of the endocannabinoid system (ECS) and its role in cannabinoid therapy. Identify common formats of medical cannabis dispensed in Australian pharmacy settings, with reference to routes of administration and clinical considerations. Recognise when medical cannabis may be considered in symptom management, and identify patient factors that influence suitability and safety. Outline the pharmacist’s responsibilities in dispensing cannabis medicines, including product handling, patient education, and regulatory compliance. Be able to counsel patients on medical cannabis products, including product selection, dosing, side effects, and legal considerations.